355 related articles for article (PubMed ID: 25196138)
1. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells.
Talarico G; Orecchioni S; Dallaglio K; Reggiani F; Mancuso P; Calleri A; Gregato G; Labanca V; Rossi T; Noonan DM; Albini A; Bertolini F
Sci Rep; 2016 Jan; 6():18673. PubMed ID: 26728433
[TBL] [Abstract][Full Text] [Related]
3. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
[TBL] [Abstract][Full Text] [Related]
4. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
[TBL] [Abstract][Full Text] [Related]
5. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
[TBL] [Abstract][Full Text] [Related]
6. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG
Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468
[TBL] [Abstract][Full Text] [Related]
7. Serine deprivation enhances antineoplastic activity of biguanides.
Gravel SP; Hulea L; Toban N; Birman E; Blouin MJ; Zakikhani M; Zhao Y; Topisirovic I; St-Pierre J; Pollak M
Cancer Res; 2014 Dec; 74(24):7521-33. PubMed ID: 25377470
[TBL] [Abstract][Full Text] [Related]
8. Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport.
Velez J; Pan R; Lee JT; Enciso L; Suarez M; Duque JE; Jaramillo D; Lopez C; Morales L; Bornmann W; Konopleva M; Krystal G; Andreeff M; Samudio I
Oncotarget; 2016 Aug; 7(32):51435-51449. PubMed ID: 27283492
[TBL] [Abstract][Full Text] [Related]
9. Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.
Reggiani F; Labanca V; Mancuso P; Rabascio C; Talarico G; Orecchioni S; Manconi A; Bertolini F
Cancer Res; 2017 Sep; 77(18):5169-5182. PubMed ID: 28754674
[TBL] [Abstract][Full Text] [Related]
10. Glucose Deprivation Enhances the Antiproliferative Effects of Oral Hypoglycemic Biguanides in Different Molecular Subtypes of Breast Cancer: an in Vitro Study.
Bardaweel SK; Alsalamat HA; Aleidi SM; Bashatwah RM
Acta Pharm; 2018 Dec; 68(4):517-524. PubMed ID: 31259708
[TBL] [Abstract][Full Text] [Related]
11. Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
Janzer A; German NJ; Gonzalez-Herrera KN; Asara JM; Haigis MC; Struhl K
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10574-9. PubMed ID: 25002509
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of deactivated mitochondrial complex I by biguanides.
Matsuzaki S; Humphries KM
Biochemistry; 2015 Mar; 54(11):2011-21. PubMed ID: 25719498
[TBL] [Abstract][Full Text] [Related]
13. lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1.
Liu X; Gan B
Cell Cycle; 2016 Dec; 15(24):3471-3481. PubMed ID: 27792451
[TBL] [Abstract][Full Text] [Related]
14. Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase.
Bridges HR; Sirviö VA; Agip AN; Hirst J
BMC Biol; 2016 Aug; 14():65. PubMed ID: 27506389
[TBL] [Abstract][Full Text] [Related]
15. The Pituitary Gland is a Novel Major Site of Action of Metformin in Non-Human Primates: a Potential Path to Expand and Integrate Its Metabolic Actions.
Vázquez-Borrego MC; Fuentes-Fayos AC; Gahete MD; Castaño JP; Kineman RD; Luque RM
Cell Physiol Biochem; 2018; 49(4):1444-1459. PubMed ID: 30205369
[TBL] [Abstract][Full Text] [Related]
16. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
17. Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.
Segal ED; Yasmeen A; Beauchamp MC; Rosenblatt J; Pollak M; Gotlieb WH
Biochem Biophys Res Commun; 2011 Nov; 414(4):694-9. PubMed ID: 21986525
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
Vigneri R; Pezzino V; Wong KY; Goldfine ID
J Clin Endocrinol Metab; 1982 Jan; 54(1):95-100. PubMed ID: 7033271
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment.
Wang J; Xia S; Zhu Z
Cell Biochem Biophys; 2015 Mar; 71(2):513-8. PubMed ID: 25312480
[TBL] [Abstract][Full Text] [Related]
20. Metformin and phenformin block the peripheral antinociception induced by diclofenac and indomethacin on the formalin test.
Ortiz MI
Life Sci; 2012 Jan; 90(1-2):8-12. PubMed ID: 22036620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]